4 December 2023
- 16:2616:26, 4 December 2023 diff hist +74 Associations List (Istituto Oncologico Veneto IRCCS-IOV) No edit summary
- 16:2516:25, 4 December 2023 diff hist +74 Novel Therapies and Diagnostic Methods (Istituto Oncologico Veneto IRCCS-IOV) No edit summary
- 16:2516:25, 4 December 2023 diff hist +75 Trainings: Institutional courses and conferences (Istituto Oncologico Veneto IRCCS-IOV) No edit summary
- 16:2416:24, 4 December 2023 diff hist +94 Training: Voluntary Attendance, Training and Orientation Internship (Istituto Oncologico Veneto IRCCS-IOV) No edit summary
- 16:2416:24, 4 December 2023 diff hist +94 Course: Master Degree "Clinical trials in oncology: clinical, managerial and operational aspects" (Istituto Oncologico Veneto IRCCS-IOV) No edit summary
- 16:2416:24, 4 December 2023 diff hist +75 Course: PhD in Clinical and Experimental Oncology and Immunology (Istituto Oncologico Veneto IRCCS-IOV) No edit summary
- 16:2316:23, 4 December 2023 diff hist +75 Experts (Istituto Oncologico Veneto IRCCS-IOV) No edit summary
- 16:2316:23, 4 December 2023 diff hist +25 Istituto Oncologico Veneto IRCCS-IOV →Trials (Istituto Oncologico Veneto IRCCS-IOV)
- 16:2216:22, 4 December 2023 diff hist +213,977 N Trials (Istituto Oncologico Veneto IRCCS-IOV) Created page with "{{forpatients}} {{forproviders}} {{forresearchers}} Go back to Istituto Oncologico Veneto IRCCS-IOV page '''NCTID''': NCT02170090 '''Title''': Adjuvant Chemotherapy With Gemcitabine and Cisplatin Compared to Standard of Care After Curative Intent Resection of Biliary Tract Cancer '''Study Summary''': This is a multicenter, prospective, randomized, controlled phase III trial designed to assess the clinical performance of gemcitabine with cisplatin and observation..."
- 16:2116:21, 4 December 2023 diff hist −5 Istituto Oncologico Veneto IRCCS-IOV →Trials
- 16:1816:18, 4 December 2023 diff hist +118 EHDEN Participation (Fondazione IRCCS- Istituto Nazionale dei Tumori di Milano) No edit summary
- 16:1716:17, 4 December 2023 diff hist +95 Facility: Travel Agency (Fondazione IRCCS- Istituto Nazionale dei Tumori di Milano) No edit summary
- 16:1716:17, 4 December 2023 diff hist +95 Facility: Holistic Parapharmacy (Fondazione IRCCS- Istituto Nazionale dei Tumori di Milano) No edit summary
- 16:1616:16, 4 December 2023 diff hist +95 Facility: A Casa Far From Home Info Point (Fondazione IRCCS- Istituto Nazionale dei Tumori di Milano) No edit summary
- 16:1616:16, 4 December 2023 diff hist +95 Resource: Patients Support Programs (Fondazione IRCCS- Istituto Nazionale dei Tumori di Milano) No edit summary
- 16:1616:16, 4 December 2023 diff hist +95 Associations List (Fondazione IRCCS- Istituto Nazionale dei Tumori di Milano) No edit summary
- 16:1616:16, 4 December 2023 diff hist +95 Novel Therapies and Diagnostic Methods (Fondazione IRCCS- Istituto Nazionale dei Tumori di Milano) No edit summary
- 16:1516:15, 4 December 2023 diff hist +115 Volunteering: Voluntary attendance (Fondazione IRCCS- Istituto Nazionale dei Tumori di Milano) No edit summary
- 16:1516:15, 4 December 2023 diff hist +115 Courses: University Programs (Fondazione IRCCS- Istituto Nazionale dei Tumori di Milano) No edit summary
- 16:1516:15, 4 December 2023 diff hist +96 Course: Degree Course in Nursing (Fondazione IRCCS- Istituto Nazionale dei Tumori di Milano) No edit summary
- 16:1416:14, 4 December 2023 diff hist +96 Trainings: Trainings Events (Fondazione IRCCS- Istituto Nazionale dei Tumori di Milano) No edit summary
- 16:1416:14, 4 December 2023 diff hist +96 Experts (Fondazione IRCCS- Istituto Nazionale dei Tumori di Milano) No edit summary
- 16:1316:13, 4 December 2023 diff hist +25 Fondazione IRCCS- Istituto Nazionale dei Tumori di Milano →Trials (Fondazione IRCCS- Istituto Nazionale dei Tumori di Milano)
- 16:1316:13, 4 December 2023 diff hist +62,808 N Trials (Fondazione IRCCS- Istituto Nazionale dei Tumori di Milano) Created page with "{{forpatients}} {{forproviders}} {{forresearchers}} Go back to Fondazione IRCCS- Istituto Nazionale dei Tumori di Milano page '''NCTID''': NCT05594290 '''Title''': Chemo-immunotherapy in Patients With Resectable Merkel Cell Carcinoma Prior to Surgery '''Study Summary''': This is a window-of-opportunity study for patients with resectable Merkel Cell Carcinoma. The aim of this study is to test the activity of a course of chemo-immunotherapy followed by surgery in..."
- 16:1216:12, 4 December 2023 diff hist −5 Fondazione IRCCS- Istituto Nazionale dei Tumori di Milano →Trials
- 16:1116:11, 4 December 2023 diff hist +68 Resource: CARE Program (European Institute of Oncology ) No edit summary
- 16:1116:11, 4 December 2023 diff hist +68 Tool: Clinical Trial Search (European Institute of Oncology) No edit summary
- 16:1116:11, 4 December 2023 diff hist +68 Facility: Anti-smoking Center (European Institute of Oncology) No edit summary
- 16:1016:10, 4 December 2023 diff hist +68 Novel Therapies and Diagnostic Methods (European Institute of Oncology) No edit summary
- 16:1016:10, 4 December 2023 diff hist +69 Training: ESAGON (European Institute of Oncology) No edit summary
- 16:1016:10, 4 December 2023 diff hist +69 Observanship: Clinical Observer (European Institute of Oncology) No edit summary
- 16:0916:09, 4 December 2023 diff hist +69 Course: IEO Web Education (European Institute of Oncology) No edit summary
- 16:0916:09, 4 December 2023 diff hist +88 Course: Specialization in Methodology and Ethics of Oncological Clinical Trials (European Institute of Oncology) No edit summary
- 16:0916:09, 4 December 2023 diff hist +69 Course: Bachelor Degree in Nursing (European Institute of Oncology) No edit summary
- 16:0816:08, 4 December 2023 diff hist +69 Course: Master Degree in Biomedical Omics (European Institute of Oncology) No edit summary
- 16:0816:08, 4 December 2023 diff hist +69 Course: Masters Degree in Psycho-Oncology (European Institute of Oncology) No edit summary
- 16:0816:08, 4 December 2023 diff hist +69 Course: SEMM - Doctoral Programs (PHD) (European Institute of Oncology) No edit summary
- 16:0816:08, 4 December 2023 diff hist +69 Course: SEMM - Postdoc Program (European Institute of Oncology) No edit summary
- 16:0716:07, 4 December 2023 diff hist +69 Experts (European Institute of Oncology) No edit summary
- 16:0616:06, 4 December 2023 diff hist +25 European Institute of Oncology →Trials (European Institute of Oncology)
- 16:0616:06, 4 December 2023 diff hist +118,371 N Trials (European Institute of Oncology) Created page with "{{forpatients}} {{forproviders}} {{forresearchers}} Go back to European Institute of Oncology page '''NCTID''': NCT05554003 '''Title''': Metronomic Temozolomide in Unfit NENs Patients Metronomic Temozolomide in Unfit Patients With Advanced Neuroendocrine Neoplasms (NENs): MeTe Study '''Study Summary''': Study design and rationale: Neuroendocrine neoplasms (NENs ) represent a heterogeneous group of malignancies, which differ in terms of behavio r and prognosis. M..."
- 16:0516:05, 4 December 2023 diff hist −5 European Institute of Oncology →Trials
- 16:0216:02, 4 December 2023 diff hist +76 Tool: Live Emergency Room (IRCCS Ospedale Policlinico San Martino) No edit summary
- 16:0016:00, 4 December 2023 diff hist +76 Resource: Wig Project (IRCCS Ospedale Policlinico San Martino) No edit summary
- 16:0016:00, 4 December 2023 diff hist +76 Resource: Group Therapies (IRCCS Ospedale Policlinico San Martino) No edit summary
- 16:0016:00, 4 December 2023 diff hist +76 Resource: Tuina (IRCCS Ospedale Policlinico San Martino) No edit summary
- 15:5915:59, 4 December 2023 diff hist +76 Resource: Acupuncture (IRCCS Ospedale Policlinico San Martino) No edit summary
- 15:5915:59, 4 December 2023 diff hist +76 Patient Association: PerLaDonna (IRCCS Ospedale Policlinico San Martino) No edit summary
- 15:5915:59, 4 December 2023 diff hist +76 Associations List (IRCCS Ospedale Policlinico San Martino) No edit summary
- 15:5815:58, 4 December 2023 diff hist +76 Novel Therapies and Diagnostic Methods (IRCCS Ospedale Policlinico San Martino) No edit summary
